Literature DB >> 823042

The establishment of continuous lymphoblastoid suspension cell cultures from hematopoietic organs of baboon (Papio hamadryas) with malignant lymphoma.

V Z Agrba, L A Yakovleva, B A Lapin, I A Sangulija, V V Timanovskaya, D S Markarjan, G N Chuvirov, E A Salmanova.   

Abstract

Two continuous suspension lymphoblastoid cell cultures designated as SPG-1 and KMPG-1 have been established from the bone marrow and spleen cells of the hamadryas baboon no. 9386 with malignant lymphoma. Virus particles morphologically characterized as herpes-like have been revealed in KMPH-1 and SPG-1 cultures in 2-10% of cells. The paper describes the establishment of these suspension cultures.

Entities:  

Mesh:

Year:  1975        PMID: 823042     DOI: 10.1016/s0014-4908(75)80040-8

Source DB:  PubMed          Journal:  Exp Pathol (Jena)        ISSN: 0014-4908


  5 in total

1.  Infection of nonhuman primate cells by pig endogenous retrovirus.

Authors:  J H Blusch; C Patience; Y Takeuchi; C Templin; C Roos; K Von Der Helm; G Steinhoff; U Martin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  Historical background.

Authors:  M A Epstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  Establishment and characteristics of an interleukin-2-dependent STLV-1-producing lymphoid cell line, SPH-7(T), obtained from Papio hamadryas with malignant lymphoma.

Authors:  V Agrba; V Timanovskaya; V Kakubava; L Indzhiia; D Araviashvili; M Chikobava; B Lapin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-10       Impact factor: 2.416

4.  Genetics of primate lymphomas in a baboon (Papio hamadryas) colony of Sukhumi, USSR.

Authors:  M H Crawford; E J Devor; D H O'Rourke; L A Yakovleva; A F Voevodin; B A Lapin
Journal:  Genetica       Date:  1987-08-31       Impact factor: 1.082

5.  Linkage map of the fragments of herpesvirus papio DNA.

Authors:  Y S Lee; A Tanaka; R Y Lau; M Nonoyama; H Rabin
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.